23 July 2024
HANetf ICAV (the ICAV)
HAN-GINS Indxx-Healthcare Megatrend Equal Weight UCITS ETF (the Sub-Fund)
Notice of Result of the Extraordinary General Meeting of the Sub-Fund
Dear Shareholder
We are writing to inform you that the following ordinary resolutions were passed at an Extraordinary General Meeting of the Sub-Fund held on 22 July 2024 at 11:00am.
1. That the amendments to the investment objective and policy of the Fund as set out in the Circular to the Shareholders of the Fund dated 28 June 2024 be and are hereby approved.
2. That the proposed increase to the total expense ratio of the Fund as set out in the Circular to the Shareholders of the Fund dated 28 June 2024 be and is hereby approved.
Subject to Central Bank approval, the proposed changes are scheduled to take effect and reflected in a revised Supplement on or around 6 August 2024 (the Effective Date).
Copies of the revised Supplement reflecting the above changes will be available on request after the Effective Date, free of charge at the registered office of the ICAV or at the offices of the foreign representatives.
Should you have any questions in relation to the above, please do not hesitate to contact HANetf Management Limited at info@hanetf.com.
Yours sincerely
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
